Zumpano Patricios, P.A. Data Breach – Levi & Korsinsky, LLP Launches Investigation

NEW YORK CITY, NY / ACCESS Newswire / August 5, 2025 / Zumpano Patricios, P.A.("ZP Law") recently disclosed that it suffered a data breach that compromised the sensitive personal and protected health data of individuals. This data breach has led to concerns over the security of sensitive personal and protected health information entrusted to ZP […]

BlockInsight Exchange Announces New Era in Intelligent Quantitative Trading

BlockInsight Exchange Announces New Era in Intelligent Quantitative Trading BlockInsight Exchange unveils a strategic alliance to drive the next phase of AI-driven trading systems. GlobeNewswire August 05, 2025 Denver, Aug. 05, 2025 (GLOBE NEWSWIRE) — BlockInsight Exchange, a leading global digital asset trading platform, today announced the formal establishment of a strategic partnership with the

WESTWOOD WELCOMES COO, DEAN PALUMBO

Westwood Professional Services, Inc. (Westwood) is thrilled to announce the appointment of Dean Palumbo as the new Chief Operating Officer (COO). Palumbo joins Westwood with an extensive background in the A&E industry and a focus on leading and building strong teams. https://mma.prnewswire.com/media/2744543/Dean_Palumbo_COO_Westwood.jpg Palumbo will oversee Westwood's operations, focusing on driving growth across all of Westwood.

August 11, 2025 Deadline Approaching: Join Class Action Against Rocket Pharmaceuticals, Inc. (RCKT) – Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / August 5, 2025 / If you suffered a loss on your Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/rocket-pharmaceuticals-inc-lawsuit-submission-form?prid=159826&wire=1&utm_campaign=30 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

WWII Memoir Launch Celebrates 80th Anniversary of VJ Day

Santa Cruz author honors her family's rescue from Japan & the U.S. Marines who saved them in heartfelt, fun, history-rich evening On the 80th Anniversary of VJ Day, local author, Laura Elliott, invites the community to a moving celebration of joy, resilience, and remembrance, centered around the launch of her just-released debut memoir, Dear Laura:

DEADLINE ALERT for RDDT, HIMS, IRBT, and CNC: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

(NYSE:RDDT),(NYSE:HIMS),(NYSE:CNC),(NASDAQ:IRBT), LOS ANGELES, Aug. 05, 2025 (GLOBE NEWSWIRE) — The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. Investors suffering losses on their investments are encouraged

DEADLINE ALERT for RDDT, HIMS, IRBT, and CNC: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

DEADLINE ALERT for RDDT, HIMS, IRBT, and CNC: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire August 05, 2025 LOS ANGELES, Aug. 05, 2025 (GLOBE NEWSWIRE) — The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of

REPL DEADLINE: Replimune Group Investors Should Contact Block & Leviton By September 22nd To Join Securities Fraud Lawsuit

(NASDAQ:REPL), BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) — Block & Leviton reminds investors that a securities fraud lawsuit has been filed against Replimune Group, Inc. (Nasdaq: REPL) and certain of its executives. Investors who have lost money in their Replimune Group, Inc. investment should contact the firm to learn more about how they might recover

Shareholder Alert: The Ademi Firm investigates whether Y-mAbs Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders

The Ademi Firm is investigating Y-mAbs (NASDAQ: YMAB) for possible breaches of fiduciary duty and other violations of law in its transaction with SERB Pharmaceuticals. https://mma.prnewswire.com/media/2672539/Ademi_Fruchter__Logo.jpg Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995. There is no cost or obligation to you.

Scroll to Top